Live investor webinar
Amplia Therapeutics Ltd Investor Briefing 30 July, 11:00 AM AEST
00
days
:
00
hrs
:
00
min
:
00
sec

Integrated Research Ltd Flags FY26 Revenue Drop as Cash Rises 27% to $51.7m

By Josua Ferreira -
  • Integrated Research guided FY26 revenue to $56–58m, down roughly 17% from FY25's $68.3m, with EBITDA swinging to a loss of ($2.0)–($4.0)m from a $15.9m profit the prior year.
  • Cash surged 27% to $51.7m from $40.6m, giving the company a materially stronger balance sheet to fund its product-led growth pivot despite the earnings deterioration.
  • Second-half new business momentum stalled after a stronger first half, with multiple new business opportunities explicitly deferred into 1H FY27 — making the first half of the new financial year a critical execution test.
  • CEO Ian Lowe flagged AI-driven caution among enterprise technology buyers as a macro headwind, with accelerating monetisation of new products and expanding client-led innovation named as the two key FY27 priorities.
  • All FY26 figures remain unaudited, with full detail to follow at the company's audited full-year results release.

Integrated Research flags FY26 revenue decline but lifts cash 27% to $51.7m

Integrated Research (ASX: IRI) has released an unaudited FY26 trading update, revealing softer revenue alongside a materially stronger cash position for the year ended 30 June 2026.

The company, a global provider of observability for business-critical IT ecosystems, guided FY26 revenue to $56–58m, down roughly 17% at the midpoint from FY25’s $68.3m. Cash climbed 27% to $51.7m, providing a strong base to fund its product-led growth strategy.

All figures in the update, released on 24 July 2026, remain subject to audit, with full detail to follow at the company’s full-year results.

FY26 results snapshot

The headline financials, presented below, combine unaudited FY26 guidance ranges with FY25 actuals. Both Revenue and Pro forma Revenue are guidance ranges pending audit.

Metric (A$’m) FY26 (unaudited guidance) FY25 (actual) % Change (midpoint vs FY25)
Revenue $56–58m $68.3m (17%)
Pro forma Revenue $64–66m $74.3m (13%)
EBITDA ($2.0)–($4.0)m $15.9m NM
Cash $51.7m $40.6m Up 27%

The EBITDA year-on-year change is reported as NM (Not meaningful). Management attributed the performance to several drivers:

IRI FY26 Financial Contrast: Revenue Decline vs. Cash Growth

  • A softer renewals book, the value of which fluctuates year on year

  • A first-half new business uplift that was not maintained in the second half

  • Multiple new business opportunities deferred into 1H FY27

  • Statutory earnings impacted by higher expected credit losses and foreign exchange losses

What “product-led growth” and “observability” mean for investors

Understanding two terms helps clarify the update. Observability refers to real-time monitoring and intelligence across complex, multi-vendor IT environments, spanning infrastructure, unified communications and customer experience (UC&CX), and payments. IR delivers this through its Prognosis platform.

Product-led growth is the company’s primary strategy to achieve sustainable new business revenue growth over the medium term.

The core challenge is straightforward: new business revenue must exceed revenue churn for the company to grow. In FY26, the rate of new business growth trailed churn, which weighed on Pro forma Revenue.

This is why cash strength matters. A robust balance sheet funds the medium-term pivot toward product-led growth, giving the company runway to execute despite a challenging year.

Why the strong cash position matters

The standout positive in the update is the $51.7m cash balance, up 27% from $40.6m a year earlier. The company described this as robust cash generation, providing strong foundations to build further product innovation momentum and continue executing its product-led growth strategy.

The balance sheet strength must be weighed against a genuinely difficult financial year. Both Revenue and Pro forma Revenue declined, and EBITDA guidance sits in a negative range of ($2.0)–($4.0)m, down from $15.9m in FY25. One modest positive: EBITDA modestly improved in the second half.

CEO and Managing Director Ian Lowe

“FY26 was a pivotal year as IR advanced its product-led growth execution, strengthening innovation, product delivery and client engagement despite challenging financial performance. With AI driving more cautious technology investment decisions, accelerating monetisation of new products and expanding client-led innovation are key priorities for FY27. IR’s position as a trusted partner to leading global organisations provides a strong platform from which to build further momentum.”

The road to FY27

Management set out clear priorities for the year ahead, anchored to its product-led growth strategy:

  1. Accelerating the monetisation of new products

  2. Expanding client-led innovation

The company flagged a cautious macro backdrop, noting that AI is driving more measured technology investment decisions among clients. IR pointed to its position as a trusted partner to leading global organisations, established over more than 30 years, as a platform from which to build further momentum.

Full detail on the FY26 numbers will accompany the company’s audited full-year results, where investors can assess how execution against these FY27 priorities is progressing.

Don’t Miss the Next ASX Tech Update

Big News Blast delivers FREE breaking ASX tech news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already staying ahead of the market. Click the “Free Alerts” button at StockWire X to get the next market-moving announcement the moment it drops.


Frequently Asked Questions

What did Integrated Research report in its FY26 trading update?

Integrated Research guided FY26 revenue to $56–58m, down approximately 17% from $68.3m in FY25, while cash rose 27% to $51.7m. EBITDA is expected to land in a loss range of ($2.0)–($4.0)m, compared to a $15.9m profit the prior year. All figures remain unaudited pending the full-year results.

Why did Integrated Research's revenue decline in FY26?

Management attributed the revenue decline to a softer renewals book, a first-half new business uplift that was not sustained in the second half, and multiple new business opportunities that were deferred into the first half of FY27. Higher expected credit losses and foreign exchange losses also weighed on statutory earnings.

What is product-led growth and why is it central to Integrated Research's strategy?

Product-led growth is IR's strategy to drive sustainable new business revenue by leading with its product — primarily the Prognosis observability platform — rather than traditional sales-led approaches. The company needs new business revenue to exceed customer churn to grow, and this strategy is designed to achieve that over the medium term.

What is observability in the context of Integrated Research's business?

Observability refers to real-time monitoring and intelligence across complex, multi-vendor IT environments, covering infrastructure, unified communications and customer experience, and payments. Integrated Research delivers this capability through its Prognosis platform to large global enterprises.

When will Integrated Research release its full audited FY26 results?

The trading update released on 24 July 2026 contains unaudited figures. Full detail on the FY26 numbers will be provided when Integrated Research releases its audited full-year results, though a specific date for that release was not disclosed in the update.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher